These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1373592)

  • 1. Modulation of multidrug resistance by immunosuppressive agents: cyclosporin analogues, FK506 and mizoribine.
    Mizuno K; Furuhashi Y; Misawa T; Iwata M; Kawai M; Kikkawa F; Kano T; Tomoda Y
    Anticancer Res; 1992; 12(1):21-5. PubMed ID: 1373592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FK506 reverses adriamycin resistance in a multidrug-resistant human leukemia cell line.
    Natazuka T
    Kobe J Med Sci; 1992 Dec; 38(6):347-63. PubMed ID: 1284834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of adriamycin cytotoxicity and transport in drug-sensitive and multidrug-resistant Chinese hamster ovary cells by hyperthermia and cyclosporin A.
    Larrivée B; Averill DA
    Cancer Chemother Pharmacol; 2000; 45(3):219-30. PubMed ID: 10663640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of multidrug resistance in Chinese hamster ovary cells by the immunosuppressive agent rapamycin.
    Hoof T; Demmer A; Christians U; Tümmler B
    Eur J Pharmacol; 1993 Jun; 246(1):53-8. PubMed ID: 7689059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FK506 completely inhibits adriamycin efflux in the adriamycin-resistant strain of Ehrlich ascites tumor cells.
    Asaumi J; Kawasaki S; Nishikawa K; Kuroda M; Takeda Y; Hiraki Y
    Anticancer Res; 1996; 16(1):247-50. PubMed ID: 8615615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of multidrug resistance by tacrolimus hydrate.
    Wu J; Furusawa S; Nakano S; Takahashi M; Chiba H; Takayanagi M; Takayanagi Y; Sasaki K
    Methods Find Exp Clin Pharmacol; 1996 Dec; 18(10):651-8. PubMed ID: 9121220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FK-506 (fujimycin) reverses the multidrug resistance of tumor cells in vitro.
    Pourtier-Manzanedo A; Boesch D; Loor F
    Anticancer Drugs; 1991 Jun; 2(3):279-83. PubMed ID: 1724925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporin A and FK506 reverse anthracycline resistance by altering the cell cycle.
    Yamamoto M; Baba H; Kusumoto T; Sakaguchi Y; Maehara Y; Kuwano M; Sugimachi K
    Anticancer Drugs; 1995 Aug; 6(4):570-7. PubMed ID: 7579561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of reversal of daunorubicin resistance in HL60/AR cells by cyclosporin A.
    Gollapudi S; Gupta S
    Anticancer Res; 1992; 12(6B):2127-32. PubMed ID: 1363515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The activity of deoxyspergualin in multidrug-resistant cells.
    Holmes JA; Twentyman PR
    Cancer Chemother Pharmacol; 1995; 36(6):499-505. PubMed ID: 7554042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance modification by PSC-833, a novel non-immunosuppressive cyclosporin [corrected].
    Twentyman PR; Bleehen NM
    Eur J Cancer; 1991; 27(12):1639-42. PubMed ID: 1816768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressants FK506 and rapamycin function as reversal agents of the multidrug resistance phenotype.
    Arceci RJ; Stieglitz K; Bierer BE
    Blood; 1992 Sep; 80(6):1528-36. PubMed ID: 1381629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct demonstration of high affinity interactions of immunosuppressant drugs with the drug binding site of the human P-glycoprotein.
    Rao US; Scarborough GA
    Mol Pharmacol; 1994 Apr; 45(4):773-6. PubMed ID: 7514263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SDZ PSC 833, a non-immunosuppressive cyclosporine: its potency in overcoming P-glycoprotein-mediated multidrug resistance of murine leukemia.
    Keller RP; Altermatt HJ; Nooter K; Poschmann G; Laissue JA; Bollinger P; Hiestand PC
    Int J Cancer; 1992 Feb; 50(4):593-7. PubMed ID: 1347037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined use of tamoxifen, cyclosporin A, and verapamil for modulating multidrug resistance in human hepatocellular carcinoma cell lines.
    Kim JH; Chung JB; Park IS; Kim BS; Yoo NC; Choi JH; Roh JK; Kim HS; Kwon OH; Lee KS
    Yonsei Med J; 1993 Mar; 34(1):35-44. PubMed ID: 8397460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of the progesterone receptor with binding proteins for FK506 and cyclosporin A.
    Milad M; Sullivan W; Diehl E; Altmann M; Nordeen S; Edwards DP; Toft DO
    Mol Endocrinol; 1995 Jul; 9(7):838-47. PubMed ID: 7476967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of cyclosporin A and a non-immunosuppressive cyclosporin against multidrug resistant leukemic cell lines.
    Hait WN; Stein JM; Koletsky AJ; Harding MW; Handschumacher RE
    Cancer Commun; 1989; 1(1):35-43. PubMed ID: 2640154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcineurin phosphatase activity and immunosuppression. A review on the role of calcineurin phosphatase activity and the immunosuppressive effect of cyclosporin A and tacrolimus.
    Jørgensen KA; Koefoed-Nielsen PB; Karamperis N
    Scand J Immunol; 2003 Feb; 57(2):93-8. PubMed ID: 12588654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FK506 and cyclosporin A inhibit granulocyte/macrophage colony-stimulating factor production by mononuclear cells in asthma.
    Sano T; Nakamura Y; Matsunaga Y; Takahashi T; Azuma M; Okano Y; Shimizu E; Ogushi F; Sone S; Ogura T
    Eur Respir J; 1995 Sep; 8(9):1473-8. PubMed ID: 8575571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human P-glycoprotein transports cyclosporin A and FK506.
    Saeki T; Ueda K; Tanigawara Y; Hori R; Komano T
    J Biol Chem; 1993 Mar; 268(9):6077-80. PubMed ID: 7681059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.